You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -170.0 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 0.0 | n/a |
| Price / Book value | 37.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | n/a | -0.19 | n/a | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | n/a | -20.17 | -0.05p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | n/a | -3.76 | -0.01p | -120.0 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|
| Okyo aims to complete eye disease trials before June Sharecast News | 24 Jan |
|---|